Today: 10 June 2026
SSE share price slips into weekend as UK rate-cut bets shift; Feb update looms
24 January 2026
1 min read

SSE share price slips into weekend as UK rate-cut bets shift; Feb update looms

London, Jan 24, 2026, 08:44 GMT — Market closed.

SSE PLC shares closed Friday on the London Stock Exchange at 2,322 pence, slipping 6 pence, or 0.26%. The stock fluctuated between 2,299 and 2,329 pence, holding close to the upper boundary of its 52-week range.

UK markets were closed Saturday, so Monday’s move hinges on whether company updates or rate decisions take the lead.

Utilities often seem dull—until bond markets shift. Rising yields hit the steady cash flows behind dividend stocks, pushing their prices down as those earnings face steeper discounting.

Morgan Stanley has shifted its forecast, now predicting the Bank of England will deliver its next rate cut in March instead of February. The BoE’s next policy meeting is scheduled for Feb. 5, where rates are expected to hold steady at 3.75%. Markets currently price in about 42.33 basis points of cuts through the end of 2026.

UK retail sales unexpectedly rose 0.4% in December, defying forecasts of a decline, while the flash S&P Global composite PMI increased to 53.9. Jonas Goltermann, deputy chief markets economist at Capital Economics, noted that “retail sales are a very volatile series.” Elliott Jordan-Doak of Pantheon Macroeconomics commented that “GDP growth is likely to pick up in Q1.” Reuters

Bank of England policymaker Megan Greene expressed caution on inflation, highlighting concerns around wage growth and inflation expectations. “I will be watching household and business inflation expectations” closely in the coming months, she said. Reuters

Equities felt the pressure from rate concerns and political jitters. The FTSE 100 dipped 0.07% on Friday, ending a three-week rally as investors grew wary of fresh geopolitical tensions sparked by U.S. President Donald Trump’s tariff threats targeting Greenland.

Not all peers moved in sync. National Grid closed Friday up 0.42%, reaching 1,191.5 pence.

The risk scenario for SSE is similar but intensified: inflation remains stubborn, rate cuts get delayed once more, and rising gilt yields continue to weigh on “bond proxy” stocks. In this environment, a standard trading update could still fall short if it fails to reinforce confidence in the dividend or the investment strategy.

SSE has two key dates coming up. The interim dividend will be paid out on Jan. 30, and the company plans to release its Q3 trading statement on Feb. 4 — a report that could shake up forecasts for the spring.

Stock Market Today

  • 3 High ROE Stocks With Solid Balance Sheets Highlighted for Investors
    June 10, 2026, 9:01 AM EDT. Investors seeking stability amid inflation and geopolitical tensions may focus on companies with high return on equity (ROE) and robust balance sheets. Regis Resources (ASX:RRL) stands out with a 25.7% ROE, strong revenue from Australian gold projects, and forecasts of earnings growth above 20%. However, it faces risks from gold price fluctuations and project approvals. Aristocrat Leisure (ASX:ALL) features as a global gaming technology leader with substantial revenue streams and solid financial fundamentals. These stocks provide potential resilience against margin pressure and volatile input costs, offering a grounded starting point for quality-focused investment research.

Latest articles

BlackBerry Drops Again; QNX Gains on the Line With June Earnings Ahead

BlackBerry Drops Again; QNX Gains on the Line With June Earnings Ahead

10 June 2026
BlackBerry shares dropped 4.84% to $8.84 Tuesday and slid further to $8.42 premarket Wednesday, erasing part of a 49% rally as investors question whether QNX and Secure Communications growth can justify recent gains ahead of Q1 fiscal 2027 earnings on June 25; the stock is now down 14.5% from last week’s close.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

10 June 2026
Nuvalent soared 39.28% to $123.25 after GSK agreed to buy the company for $124 per share in cash, leaving a narrow 0.6% spread as investors shift focus to the $10.6 billion merger’s tender-offer timing, antitrust review, and FDA decision dates for two lung-cancer drugs in September and November 2026.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Previous Story

Stock Market Today 24.01.2026

Fortinet stock jumps on TD Cowen upgrade — what FTNT investors watch before earnings
Next Story

Fortinet stock jumps on TD Cowen upgrade — what FTNT investors watch before earnings

Go toTop